Literature DB >> 28364927

Preliminary results from direct-to-facility vaccine deliveries in Kano, Nigeria.

Muyi Aina1, Uchenna Igbokwe2, Leke Jegede2, Rabiu Fagge3, Adam Thompson4, Nasir Mahmoud3.   

Abstract

OBJECTIVE: As part of its vaccine supply chain redesign efforts, Kano state now pushes vaccines directly from 6 state stores to primary health centers equipped with solar refrigerators. Our objective is to describe preliminary results from the first 20months of Kano's direct vaccine delivery operations.
METHODS: This is a retrospective review of Kano's direct vaccine delivery program. We analyzed trends in health facility vaccine stock levels, and examined the relationship between stock-out rates and each of cascade vaccine deliveries and timeliness of deliveries. Analysis of vaccination trends was based on administrative data from 27 sentinel health facilities. Costs for both the in-sourced and out-sourced approaches were estimated using a bottoms-up model-based approach.
RESULTS: Overall stock adequacy increased from 54% in the first delivery cycle to 68% by cycle 33. Conversely, stock-out rates decreased from 41% to 10% over the same period. Similar trends were observed in the out-sourced and in-sourced programs. Stock-out rates rose incrementally with increasing number of cascade facilities, and delays in vaccine deliveries correlated strongly with stock-out rates. Recognizing that stock availability is one of many factors contributing to vaccinations, we nonetheless compared pre- and post- direct deliveries vaccinations in sentinel facilities, and found statistically significant upward trends for 4 out of 6 antigens. 1 antigen (measles) showed an upward trend that was not statistically significant. Hepatitis b vaccinations declined during the period. Overall, there appeared to be a one-year lag between commencement of direct deliveries and the increase in number of vaccinations. Weighted average cost per delivery is US$29.8 and cost per child immunized is US$0.7 per year.
CONCLUSION: Direct vaccine delivery to health facilities in Kano, through a streamlined architecture, has resulted in decreased stock-outs and improved stock adequacy. Concurrent operation of insourced and outsourced programs has enabled Kano build in-house logistics capabilities.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Immunization; Kano; Nigeria; Outsourcing costs; Vaccine delivery; Vaccine logistics; Vaccine supply chain

Mesh:

Substances:

Year:  2017        PMID: 28364927     DOI: 10.1016/j.vaccine.2016.11.100

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  The Lancet Nigeria Commission: investing in health and the future of the nation.

Authors:  Ibrahim Abubakar; Sarah L Dalglish; Blake Angell; Olutobi Sanuade; Seye Abimbola; Aishatu Lawal Adamu; Ifedayo M O Adetifa; Tim Colbourn; Afolabi Olaniyi Ogunlesi; Obinna Onwujekwe; Eme T Owoaje; Iruka N Okeke; Adebowale Adeyemo; Gambo Aliyu; Muktar H Aliyu; Sani Hussaini Aliyu; Emmanuel A Ameh; Belinda Archibong; Alex Ezeh; Muktar A Gadanya; Chikwe Ihekweazu; Vivianne Ihekweazu; Zubairu Iliyasu; Aminatu Kwaku Chiroma; Diana A Mabayoje; Mohammed Nasir Sambo; Stephen Obaro; Adesola Yinka-Ogunleye; Friday Okonofua; Tolu Oni; Olu Onyimadu; Muhammad Ali Pate; Babatunde L Salako; Faisal Shuaib; Fatimah Tsiga-Ahmed; Fatima H Zanna
Journal:  Lancet       Date:  2022-03-15       Impact factor: 202.731

2.  Improving the availability of vaccines in primary healthcare facilities in South Africa: is the time right for a system redesign process?

Authors:  Chinwe Juliana Iwu-Jaja; Portia Jordan; Ntombenhle Ngcobo; Anelisa Jaca; Chidozie Declan Iwu; Modest Mulenga; Charles Wiysonge
Journal:  Hum Vaccin Immunother       Date:  2022-03-29       Impact factor: 3.452

3.  Optimized supply chain model reduces health system costs in DRC.

Authors:  Dorothy Thomas; Eomba Motomoke; Jessica Crawford; Olivier Defawe; Archimede Makaya; Jean Willy Ngwato; Joel Bompongo; Jose Monzembela; Gabriella Ailstock; Emily Bancroft; Bvudzai Magadzire; Dominique Baabo; Noel Watson
Journal:  Vaccine       Date:  2021-06-12       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.